Advanced Cell Technology gets 2 patents related to retinal cells

09/15/2010 | Mass High Tech (Boston)

Advanced Cell Technology has received a patent to use retinal pigment epithelial cells derived from human embryonic stem cells in the treatment of retinal degeneration. The company also received another patent that allows it to produce RPE cells for use in transplantation. The patents will enable the company to test its cell treatment for Stargardt's disease.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR